HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emergence and nosocomial transmission of ampicillin-resistant enterococci.

Abstract
Between 1986 and 1988, the incidence of ampicillin-resistant enterococci increased sevenfold at a university-affiliated hospital. Forty-three patients acquired nosocomial infections with ampicillin-resistant enterococci, most of which were also resistant to mezlocillin, piperacillin, and imipenem. An analysis of plasmid and chromosomal DNAs of isolates revealed that the increase was due to an epidemic of 19 nosocomial infections that yielded closely related strains of Enterococcus faecium and to a significant increase in the incidence of nonepidemic, largely unrelated strains of ampicillin-resistant enterococci. The nonepidemic strains were identified as E. faecium, E. raffinosus, E. durans, and E. gallinarum. A logistic regression analysis revealed that patients with nonepidemic resistant strains were 16 times more likely than controls to have received preceding therapy with imipenem. In our institution, the increase in the incidence of ampicillin-resistant enterococci appears to be due to the selection of various strains of resistant enterococci by the use of imipenem and to the nosocomial transmission of E. faecium and E. raffinosus.
AuthorsJ M Boyce, S M Opal, G Potter-Bynoe, R G LaForge, M J Zervos, G Furtado, G Victor, A A Medeiros
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 36 Issue 5 Pg. 1032-9 (May 1992) ISSN: 0066-4804 [Print] United States
PMID1510390 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Ampicillin Resistance
  • Cross Infection (epidemiology, microbiology)
  • Electrophoresis, Agar Gel
  • Enterococcus (drug effects, genetics)
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: